Xuehong Liu

2.4k total citations
98 papers, 1.9k citations indexed

About

Xuehong Liu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xuehong Liu has authored 98 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 22 papers in Pathology and Forensic Medicine and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xuehong Liu's work include Spinal Cord Injury Research (19 papers), Nerve injury and regeneration (15 papers) and Ion channel regulation and function (12 papers). Xuehong Liu is often cited by papers focused on Spinal Cord Injury Research (19 papers), Nerve injury and regeneration (15 papers) and Ion channel regulation and function (12 papers). Xuehong Liu collaborates with scholars based in China, United States and United Kingdom. Xuehong Liu's co-authors include Benson O. A. Botchway, Yong Zhang, David C. Dawson, S. I. Helman, Bonnie L. Blazer‐Yost, Nabil J. Alkayed, Songou Zhang, Catherine M. Davis, Jingying Zhou and Ruihua Fan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Xuehong Liu

95 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuehong Liu China 26 1.0k 408 263 216 158 98 1.9k
Joo‐Won Jeong South Korea 27 1.6k 1.6× 221 0.5× 105 0.4× 163 0.8× 309 2.0× 57 3.1k
Eiji Warabi Japan 31 1.5k 1.5× 167 0.4× 121 0.5× 156 0.7× 438 2.8× 81 2.8k
M. Bastide France 21 820 0.8× 395 1.0× 124 0.5× 265 1.2× 239 1.5× 57 1.9k
Giovanni M. Pitari United States 22 1.1k 1.1× 149 0.4× 312 1.2× 185 0.9× 500 3.2× 53 2.4k
Mao Zhang China 26 1.5k 1.5× 156 0.4× 258 1.0× 105 0.5× 247 1.6× 78 2.4k
Yi‐Chao Lee Taiwan 32 1.4k 1.4× 200 0.5× 96 0.4× 409 1.9× 169 1.1× 90 2.8k
Xiaojuan Liu China 27 1.3k 1.3× 131 0.3× 235 0.9× 280 1.3× 308 1.9× 115 2.7k
Yan Zhou China 27 1.2k 1.2× 184 0.5× 117 0.4× 202 0.9× 210 1.3× 95 2.3k
Jennifer Q. Kwong United States 23 2.5k 2.4× 119 0.3× 298 1.1× 280 1.3× 375 2.4× 43 3.3k

Countries citing papers authored by Xuehong Liu

Since Specialization
Citations

This map shows the geographic impact of Xuehong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehong Liu more than expected).

Fields of papers citing papers by Xuehong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuehong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehong Liu. The network helps show where Xuehong Liu may publish in the future.

Co-authorship network of co-authors of Xuehong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuehong Liu. A scholar is included among the top collaborators of Xuehong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuehong Liu. Xuehong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Botchway, Benson O. A., et al.. (2024). Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease. Molecular Neurobiology. 62(3). 3493–3507. 8 indexed citations
3.
Wang, Qianhui, et al.. (2024). OTULIN Can Improve Spinal Cord Injury by the NF-κB and Wnt/β-Catenin Signaling Pathways. Molecular Neurobiology. 61(11). 8820–8830. 2 indexed citations
4.
Botchway, Benson O. A., et al.. (2023). Sestrin2 can alleviate endoplasmic reticulum stress to improve traumatic brain injury by activating AMPK/mTORC1 signaling pathway. Metabolic Brain Disease. 39(3). 439–452. 6 indexed citations
5.
Botchway, Benson O. A., Xuehong Liu, Yu Zhou, & Marong Fang. (2023). Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine. Journal of Translational Medicine. 21(1). 351–351. 11 indexed citations
6.
Huang, Min, Xizhi Wang, Benson O. A. Botchway, Yong Zhang, & Xuehong Liu. (2023). The role of long noncoding ribonucleic acids in the central nervous system injury. Molecular and Cellular Biochemistry. 479(10). 2581–2595. 1 indexed citations
7.
Botchway, Benson O. A., et al.. (2023). Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease. Food & Function. 14(12). 5537–5550. 7 indexed citations
8.
Wang, Xichen, Benson O. A. Botchway, Yong Zhang, Min Huang, & Xuehong Liu. (2023). Maresin1 can be a potential therapeutic target for nerve injury. Biomedicine & Pharmacotherapy. 161. 114466–114466. 3 indexed citations
9.
Wang, Lu, Benson O. A. Botchway, & Xuehong Liu. (2021). The Repression of the HMGB1-TLR4-NF-κB Signaling Pathway by Safflower Yellow May Improve Spinal Cord Injury. Frontiers in Neuroscience. 15. 803885–803885. 17 indexed citations
10.
Hu, Songfeng, et al.. (2020). Valproic Acid: A Potential Therapeutic for Spinal Cord Injury. Cellular and Molecular Neurobiology. 41(7). 1441–1452. 5 indexed citations
11.
Zhou, Jingying, et al.. (2018). Beneficial Effects of Resveratrol-Mediated Inhibition of the mTOR Pathway in Spinal Cord Injury. Neural Plasticity. 2018. 1–8. 23 indexed citations
12.
Liu, Xuehong, Catherine M. Davis, & Nabil J. Alkayed. (2017). P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection. Antioxidants and Redox Signaling. 28(10). 987–1007. 27 indexed citations
13.
Wang, Xiaodan, Xuehong Liu, & Ju Huang. (2017). Synthesis, Characterization of Zinc Complexes with Neutral ?-Diimine Ligands and Application in Ring-opening Polymerization of ?-Caprolactone. CHIMIA International Journal for Chemistry. 71(11). 773–773. 4 indexed citations
14.
Du, Wen, Chunlong Sun, Jun Wang, et al.. (2017). Conditions and Regulation of Mixed Culture to Promote Shiraia bambusicola and Phoma sp. BZJ6 for Laccase Production. Scientific Reports. 7(1). 17801–17801. 15 indexed citations
15.
Xu, Dandan, Chong Wang, Liliang Wei, et al.. (2015). Association of the FCN2 Gene Single Nucleotide Polymorphisms with Susceptibility to Pulmonary Tuberculosis. PLoS ONE. 10(9). e0138356–e0138356. 14 indexed citations
16.
Yang, Chao-Ling, Xuehong Liu, Alexander Paliege, et al.. (2006). WNK1 and WNK4 modulate CFTR activity. Biochemical and Biophysical Research Communications. 353(3). 535–540. 44 indexed citations
17.
Serrano, José Ramón, et al.. (2006). CFTR: Ligand Exchange between a Permeant Anion ([Au(CN)2]−) and an Engineered Cysteine (T338C) Blocks the Pore. Biophysical Journal. 91(5). 1737–1748. 19 indexed citations
18.
Helman, S. I., Xuehong Liu, & Bonnie L. Blazer‐Yost. (1996). Early response of A6 epithelia to aldosterone is mediated by vesicle trafficking of apical Na+ channels and not open probability. The FASEB Journal. 10(3). 2 indexed citations
19.
Blazer‐Yost, Bonnie L., Xuehong Liu, & S. I. Helman. (1996). Insulin stimulated Na" transport is mediated by increase of apical Na' channels and not open probability in control and aldosterone prestimulated A6 EP1thelia. The FASEB Journal. 10(3). 3 indexed citations
20.
Helman, S. I., Xuehong Liu, & J. Willem. (1995). Vesicle trafficking and aldosterone-stimulated Na+ transport in A6 epithelia. The Journal of General Physiology. 106(6). 42–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026